date,title,source
Oct-19-18,Innovate Biopharmaceuticals adds $5.2M to its coffers,American City Business Journals
Oct-29-18,Innovate Biopharmaceuticals Announces Positive Effect of Larazotide Acetate on reducing Intestinal Permeability in a NASH Preclinical Study,GlobeNewswire
Oct-31-18,Innovate Biopharmaceuticals Announces Participation at the Jefferies 2018 London Healthcare Conference,GlobeNewswire
Nov-05-18,"Innovate Biopharmaceuticals Announces Presentation at the BIO-Europe Conference, Copenhagen 2018 - 24th Annual Partnering Conference",GlobeNewswire
Nov-12-18,Sanyal Biotechnology and Innovate Biopharmaceuticals Present Data at AASLD Validating a Proprietary Leaky Gut Assay Demonstrating Reduced Intestinal Permeability with Larazotide Acetate Treatment in a NASH Preclinical Study,GlobeNewswire
Nov-13-18,Innovate Biopharmaceuticals Reports Third Quarter 2018 Earnings and Key Corporate Highlights,GlobeNewswire
